/Companies

Preludedx

Nashville, US · 3 known investors

Find your way into Preludedx

Sign up to see every warm intro you have to Preludedx

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Preludedx team. We find them
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

PreludeDx develops precision diagnostic tests for breast cancer to help physicians make informed treatment decisions and improve patient outcomes. The company serves oncologists, breast surgeons, and pathologists requiring molecular diagnostics for DCIS and other breast cancer subtypes.

Founders & leadership

TB
Troy BremerCo-founder & Chief Scientific Officer
DFDaniel Forche
Daniel ForchePresident & CEO

Investors · 3

Non-dilutive funding · 2 SBIR/STTR awards

Federal grants — no equity taken
AgencyPhaseYearAmount
National Institutes of Health (NIH)National Institutes of HealthPhase II2014$1.2M
National Institutes of Health (NIH)National Institutes of HealthPhase I2012$273.9K

Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.

Frequently asked questions

What does Preludedx do?
PreludeDx develops precision diagnostic tests for breast cancer to help physicians make informed treatment decisions and improve patient outcomes. The company serves oncologists, breast surgeons, and pathologists requiring molecular diagnostics for DCIS and other breast cancer subtypes.
Who founded Preludedx?
Preludedx was founded by Troy Bremer.
Who are Preludedx's investors?
Preludedx's investors include Fjord Ventures, BlueStone Venture Partners, Evidity Health Capital.
Where is Preludedx headquartered?
Preludedx is headquartered in Nashville, US.